Aesthetic Medicine Market (By Procedure Type: Non-Invasive Procedure, Invasive Procedure; Product Type: Energy-Based Devices, Implants, Anti-Wrinkle Products; By Application: Surgical, Non-Surgical; By End-User: Medical Spas and Beauty Centres, Hospitals and Clinics, Home Use; By Gender: Males, Females; By Route of Administration: Oral, Topical) )- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Aesthetic Medicine Market Size and Growth

The global aesthetic medicine market size was valued at USD 84.11 billion in 2023 and is anticipated to reach around USD 212.67 billion by 2033, growing at a CAGR of 9.72% from 2024 to 2033.

Aesthetic Medicine Market Size, 2024 to 2033

Aesthetic Medicine Market Key Takeaways

  • In 2023, North America accounted for the largest share of 41.92% of the global aesthetic medicine market revenue.
  • Asia Pacific is projected to grow at the highest CAGR during the forecast period.
  • The non-invasive procedures segment dominated the market with a share of 39.11% in 2023 and is expected to grow at the fastest CAGR over the forecast period.

Aesthetic Medicine Market Growth 

A significant driver for the thriving aesthetic medicine market is the rising societal focus on individual appearance, propelling an increased desire for aesthetic procedures. This shift in cultural norms, combined with an expanding awareness of the diverse cosmetic solutions now accessible, has played a pivotal role in driving the market's upward trajectory. The growing acknowledgment and acceptance of various cosmetic interventions reflect an evolving mindset towards personal aesthetic enhancement, serving as a key driver in sustaining the aesthetic market's growth.

The 2022 data from the International Society of Aesthetic Plastic Surgery (ISAPS) highlights key trends in the top five global surgical procedures, providing insights into the factors shaping the aesthetic medicine market. Liposuction emerged as the most performed procedure, totaling 2,303,929, followed closely by Breast Augmentation at 2,174,616. Eyelid Surgery secured the third position with 1,409,103, and Abdominoplasty claimed the fourth spot with 1,180,623. The fifth spot was occupied by Breast Lift, recording 955,026 procedures.

Thus, the market has witnessed a spike during the past few months and is expected to be in high demand throughout the forecasted period. The growing awareness about fitness and overall appearance has increased the demand for aesthetic treatments in developing countries. Aesthetic procedures, such as liposuction, nose reshaping, and Botox injections, are gaining consumer interest in countries, such as India and South Korea. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2022, India was ranked among the top 5 countries performing non-surgical procedures at a global level. This highlights the lucrative growth prospects that lie ahead for industry players in the country.

Aesthetic Medicine Market Report Scope

Report Attribute Details
Market Size in 2024 USD 92.29 Billion
Market Size by 2033 USD 212.67 Billion
Growth Rate From 2024 to 2033 CAGR of 9.72%
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Procedure, Product, Application, End-User, Gender, Route of Administration, Geography
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Key Companies Profiled AbbVie Inc., Galderma, Alma Lasers, Cynosure, Johnson & Johnson Private Limited, Lumenis Be Ltd., Solta Medical, Candela Medical, Hologic, Inc., Dentsply Sirona

Aesthetic Medicine Market By Procedure Type Insights

Based on procedure type, the industry has been segmented into invasive procedures and non-invasive procedures. The non-invasive procedures segment dominated the market with a share of 39.11% in 2023 and is expected to grow at the fastest CAGR over the forecast period. Less pain, instant results, and low cost are some of the factors that have boosted the demand for non-invasive procedures at a global level. Popular non-invasive procedures include Botox injections, soft tissue fillers, and chemical peel. Moreover, invasive procedures, such as liposuction, breast augmentation, and nose reshaping, are some of the popular aesthetic procedures. The growing focus on physical appearance has increased the demand for these invasive procedures.

Aesthetic Medicine Market By Regional Insights

In 2023, North America accounted for the largest share of 41.92% of the global aesthetic medicine market revenue. Advanced healthcare infrastructure, high adoption of cosmetic procedures, increasing prevalence of skin disorders, and the presence of several certified & skilled cosmetic surgeons in the region are some of the major factors contributing to the growth of the regional market.

Aesthetic Medicine Market Share, By Region, 2023 (%)

In 2022, the International Society of Aesthetic Plastic Surgery (ISAPS) revealed that a substantial number of aesthetic procedures were performed in the United States, totaling 7,448,196. This data underscores the country's continued popularity and demand for aesthetic enhancements, thus driving the U.S. aesthetic medicine market.

Asia Pacific is projected to grow at the highest CAGR during the forecast period. The region is backed by countries, such as China, India, Malaysia and South Korea. The availability of technologically advanced products and growing focus on physical appearance also support the growth. Moreover, South Korea is considered the hub of cosmetic surgeries, which is another key factor driving regional growth.

Key Aesthetic Medicine Company Insights

Some of the key players operating in the market include AbbVie; Cynosure; Evolus Inc.; Revance Therapeutics, Inc; Galderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser.

  • AbbVie is a global pharmaceutical company that focuses on the development of advanced therapies in multiple therapeutic areas. AbbVie's diverse portfolio includes medications for conditions such as rheumatoid arthritis, cancer, hepatitis C, and Parkinson's disease. AbbVie is committed to advancing science and innovation to address unmet medical needs and improve patient outcomes. With a diverse portfolio and a focus on research and development.
  • Alma Lasers is a global medical and aesthetic device company that specializes in the development and manufacturing of laser, light-based, and radiofrequency devices for various medical and cosmetic applications. Alma Lasers has gained recognition for its innovative technologies used in dermatology, plastic surgery, aesthetics, and other medical specialties. The company's product portfolio includes devices for skin rejuvenation, hair removal, tattoo removal, and body contouring. Alma Lasers is known for its commitment to advancing non-invasive and minimally invasive solutions, catering to the growing demand for aesthetic and medical procedures with reduced downtime.

The global market is highly fragmented with many local players competing with international players. However, the strict regulatory approval process is challenging the entry of new products into the market. Primary parameters affecting the competitive nature are the rapid adoption of advanced devices for improved treatment and technological advancement. Leading players are adopting various strategies, such as mergers & acquisitions, to retain their industry share and position. For instance,

  • In December 2021, Allergen Aesthetics, part of AbbVie, acquired a medical technology company, Soliton, Inc. This acquisition helped strengthen its portfolio of non-invasive body contouring treatments
  • In September 2020, Allergan Aesthetics, part of AbbVie and Skinbetter Science, announced the launch of a new educational partnership DREAM: Driving Racial Equity in Aesthetic Medicine initiative. The Dream Initiative™ is committed to advancing the principles of racial and ethnic diversity, inclusion, respect, and understanding in the fields of plastic surgery and dermatology
  • In March 2020, Galderma announced a significant investment in its aesthetic portfolio including expansion of U.S. salesforce and digital advancements in ASPIRE Galderma Rewards. Such investments have strengthened its position in the medical aesthetics market

Aesthetic Medicine Market Top Key Companies:

  • AbbVie Inc.
  • Galderma
  • Alma Lasers
  • Cynosure
  • Johnson & Johnson Private Limited
  • Lumenis Be Ltd.
  • Solta Medical
  • Candela Medical
  • Hologic, Inc.
  • Dentsply Sirona

Aesthetic Medicine Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Aesthetic Medicine market.

By Procedure Type

  • Non-Invasive Procedure
    • Botox Injections
    • Microdermabrasion
    • Soft Tissue Fillers
    • Laser Hair Removal
    • Chemical Peel
    • Others
  • Invasive Procedure
    • Liposuction
    • Nose Reshaping
    • Breast Augmentation
    • Tummy Tuck
    • Eyelid Surgery
    • Others

By Product Type

  • Energy-Based Devices
    • Laser-based Aesthetic Device
    • Radiofrequency (RF)-based Aesthetic Device
    • Light-based Aesthetic Device
    • Ultrasound Aesthetic Device
    • Others
  • Implants
    • Facial Implants
    • Breast Implants
    • Others
  • Anti-Wrinkle Products
  • Botulinum Toxin
  • Dermal Fillers
  • Others

By Application

  • Surgical
  • Non-Surgical

By End-User

  • Medical Spas and Beauty Centres
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Home Use

By Gender

  • Males
    • 18 years and below
    • 19-34 years
    • 35-50 years
    • 51-64 years
    • 65 years and above
  • Females
    • 18 years and below
    • 19-34 years
    • 35-50 years
    • 51-64 years
    • 65 years and above

By Route of Administration

  • Oral
  • Topical

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global aesthetic medicine market size was valued at USD 84.11 billion in 2023 and is anticipated to reach around USD 212.67 billion by 2033

Some key players operating in the aesthetic medicine market include Allergan, Hologic (cynosure), Johnson & Johnson, Galderma, Lumenis, Solta Medical, Syneron candela, and Alma Laser.

Key factors that are driving the aesthetic medicine market growth include innovation in aesthetic devices in the past decade. The introduction of technically advanced products, such as non-invasive body contouring systems using controlled cooling technology is projected to create growth opportunities for the market in near future.

The global aesthetic medicine market is expected to grow at a compound annual growth rate of 9.72% from 2023 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Route of Administration Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Aesthetic Medicine Market 

5.1. COVID-19 Landscape: Aesthetic Medicine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Aesthetic Medicine Market, By Product Type

8.1. Aesthetic Medicine Market, by Product Type, 2024-2033

8.1.1. Energy-Based Devices

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Implants

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Anti-Wrinkle Products

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Dermal Fillers

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Botulinum Toxin

8.1.5.1. Market Revenue and Forecast (2021-2033)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Aesthetic Medicine Market, By Procedure Type

9.1. Aesthetic Medicine Market, by Procedure Type, 2024-2033

9.1.1. Non-Invasive Procedure

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Invasive Procedure

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Aesthetic Medicine Market, By Application Type 

10.1. Aesthetic Medicine Market, by Application Type, 2024-2033

10.1.1. Surgical

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Non-Surgical

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Aesthetic Medicine Market, By End-User Type

11.1. Aesthetic Medicine Market, by End-User Type, 2024-2033

11.1.1. Medical Spas and Beauty Centres

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Hospitals and Clinics

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Ambulatory Surgical Centers

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Aesthetic Medicine Market, By Gender

12.1. Aesthetic Medicine Market, by Gender, 2024-2033

12.1.1. Males

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Females

12.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Aesthetic Medicine Market, By Route of Administration

13.1. Aesthetic Medicine Market, by Procedure Type, 2024-2033

13.1.1. Oral

13.1.1.1. Market Revenue and Forecast (2021-2033)

13.1.2. Topical

13.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 14. Global Aesthetic Medicine Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product (2021-2033)

14.1.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.1.3. Market Revenue and Forecast, by Application (2021-2033)

14.1.4. Market Revenue and Forecast, by End-User (2021-2033)

14.1.5. Market Revenue and Forecast, by Gender (2021-2033)

14.1.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Product (2021-2033)

14.1.7.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.1.7.3. Market Revenue and Forecast, by Application (2021-2033)

14.1.7.4. Market Revenue and Forecast, by End-User (2021-2033)

14.1.8. Market Revenue and Forecast, by Gender (2021-2033)

14.1.8.1. Market Revenue and Forecast, by Route of Administration (2021-2033) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product (2021-2033)

14.1.9.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.1.9.3. Market Revenue and Forecast, by Application (2021-2033)

14.1.9.4. Market Revenue and Forecast, by End-User (2021-2033)

14.1.10. Market Revenue and Forecast, by Gender (2021-2033)

14.1.11. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product (2021-2033)

14.2.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.2.3. Market Revenue and Forecast, by Application (2021-2033)

14.2.4. Market Revenue and Forecast, by End-User (2021-2033) 

14.2.5. Market Revenue and Forecast, by Gender (2021-2033)

14.2.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product (2021-2033)

14.2.8.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.2.8.3. Market Revenue and Forecast, by Application (2021-2033)

14.2.9. Market Revenue and Forecast, by End-User (2021-2033) 

14.2.10. Market Revenue and Forecast, by Gender (2021-2033)

14.2.10.1. Market Revenue and Forecast, by Route of Administration (2021-2033) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Product (2021-2033)

14.2.11.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.2.11.3. Market Revenue and Forecast, by Application (2021-2033)

14.2.12. Market Revenue and Forecast, by End-User (2021-2033)

14.2.13. Market Revenue and Forecast, by Gender (2021-2033)

14.2.14. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Product (2021-2033)

14.2.15.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.2.15.3. Market Revenue and Forecast, by Application (2021-2033)

14.2.15.4. Market Revenue and Forecast, by End-User (2021-2033)

14.2.16. Market Revenue and Forecast, by Gender (2021-2033)

14.2.16.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Product (2021-2033)

14.2.17.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.2.17.3. Market Revenue and Forecast, by Application (2021-2033)

14.2.17.4. Market Revenue and Forecast, by End-User (2021-2033)

14.2.18. Market Revenue and Forecast, by Gender (2021-2033)

14.2.18.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product (2021-2033)

14.3.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.3.3. Market Revenue and Forecast, by Application (2021-2033)

14.3.4. Market Revenue and Forecast, by End-User (2021-2033)

14.3.5. Market Revenue and Forecast, by Gender (2021-2033)

14.3.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Product (2021-2033)

14.3.7.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.3.7.3. Market Revenue and Forecast, by Application (2021-2033)

14.3.7.4. Market Revenue and Forecast, by End-User (2021-2033)

14.3.8. Market Revenue and Forecast, by Gender (2021-2033)

14.3.9. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Product (2021-2033)

14.3.10.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.3.10.3. Market Revenue and Forecast, by Application (2021-2033)

14.3.10.4. Market Revenue and Forecast, by End-User (2021-2033)

14.3.11. Market Revenue and Forecast, by Gender (2021-2033)

14.3.11.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Product (2021-2033)

14.3.12.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.3.12.3. Market Revenue and Forecast, by Application (2021-2033)

14.3.12.4. Market Revenue and Forecast, by End-User (2021-2033)

14.3.12.5. Market Revenue and Forecast, by Gender (2021-2033)

14.3.12.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Product (2021-2033)

14.3.13.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.3.13.3. Market Revenue and Forecast, by Application (2021-2033)

14.3.13.4. Market Revenue and Forecast, by End-User (2021-2033)

14.3.13.5. Market Revenue and Forecast, by Gender (2021-2033)

14.3.13.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product (2021-2033)

14.4.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.4.3. Market Revenue and Forecast, by Application (2021-2033)

14.4.4. Market Revenue and Forecast, by End-User (2021-2033)

14.4.5. Market Revenue and Forecast, by Gender (2021-2033)

14.4.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Product (2021-2033)

14.4.7.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.4.7.3. Market Revenue and Forecast, by Application (2021-2033)

14.4.7.4. Market Revenue and Forecast, by End-User (2021-2033)

14.4.8. Market Revenue and Forecast, by Gender (2021-2033)

14.4.9. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Product (2021-2033)

14.4.10.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.4.10.3. Market Revenue and Forecast, by Application (2021-2033)

14.4.10.4. Market Revenue and Forecast, by End-User (2021-2033)

14.4.11. Market Revenue and Forecast, by Gender (2021-2033)

14.4.12. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Product (2021-2033)

14.4.13.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.4.13.3. Market Revenue and Forecast, by Application (2021-2033)

14.4.13.4. Market Revenue and Forecast, by End-User (2021-2033)

14.4.13.5. Market Revenue and Forecast, by Gender (2021-2033)

14.4.13.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Product (2021-2033)

14.4.14.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.4.14.3. Market Revenue and Forecast, by Application (2021-2033)

14.4.14.4. Market Revenue and Forecast, by End-User (2021-2033)

14.4.14.5. Market Revenue and Forecast, by Gender (2021-2033)

14.4.14.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product (2021-2033)

14.5.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.5.3. Market Revenue and Forecast, by Application (2021-2033)

14.5.4. Market Revenue and Forecast, by End-User (2021-2033)

14.5.5. Market Revenue and Forecast, by Gender (2021-2033)

14.5.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Product (2021-2033)

14.5.7.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.5.7.3. Market Revenue and Forecast, by Application (2021-2033)

14.5.7.4. Market Revenue and Forecast, by End-User (2021-2033)

14.5.8. Market Revenue and Forecast, by Gender (2021-2033)

14.5.8.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product (2021-2033)

14.5.9.2. Market Revenue and Forecast, by Procedure (2021-2033)

14.5.9.3. Market Revenue and Forecast, by Application (2021-2033)

14.5.9.4. Market Revenue and Forecast, by End-User (2021-2033)

14.5.9.5. Market Revenue and Forecast, by Gender (2021-2033)

14.5.9.6. Market Revenue and Forecast, by Route of Administration (2021-2033)

Chapter 15. Company Profiles

15.1. AbbVie Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Galderma

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Alma Lasers

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Cynosure

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Johnson & Johnson Private Limited

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Lumenis Be Ltd.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Solta Medical

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Candela Medical

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Hologic, Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Dentsply Sirona

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

 

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-img Cross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert